Skip to main content
AmigoFish

EMERGENT-5: Cobenfy and Treatment Durability

From Psychopharmacology and Psychiatry Updates · · 12 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this episode, we sit down with Dr. Oliver Freudenreich to unpack EMERGENT-5, the year-long trial tracking Cobenfy's real-world durability and safety in schizophrenia. We explore whether early symptom gains hold up over time, what side effects persist, and why blood pressure monitoring now deserves a permanent spot on your checklist.

Faculty: Oliver Freudenreich, M.D., F.A.C.L.P. Host: Richard Seeber, M.D.

- Learn more about our membership here

- Earn 0.5 CME: Quick Take Vol. 85

- Xanomeline-Trospium Long-Term: Does Efficacy and Safety Hold Up After One Year?

Back to Psychopharmacology and Psychiatry Updates · Report a problem